FocusCOMBINATION KILLERS

Is all cancer therapy immunotherapy?

Science Translational Medicine  25 Nov 2015:
Vol. 7, Issue 315, pp. 315fs48
DOI: 10.1126/scitranslmed.aad7661

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

Researchers must renew efforts to decipher how standard chemotherapies enhance the effects of targeted immunotherapeutic agents (Müller et al., this issue).

View Full Text